TrialOncotarget2016

Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.

Qian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.